Nicole Negar Davarpanah - 29 Dec 2025 Form 4 Insider Report for Cidara Therapeutics, Inc. (CDTX)

Role
Chief Medical Officer
Signature
/s/ Shane Ward, Attorney-in-Fact
Issuer symbol
CDTX
Transactions as of
29 Dec 2025
Net transactions value
$0
Form type
4
Filing time
29 Dec 2025, 18:04:38 UTC
Previous filing
12 Dec 2025
Next filing
07 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Davarpanah Nicole Negar Chief Medical Officer 6310 NANCY RIDGE DRIVE, SUITE 101, SAN DIEGO /s/ Shane Ward, Attorney-in-Fact 29 Dec 2025 0002067554

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDTX Common Stock Gift $0 -450 -2.1% $0.000000 20,886 29 Dec 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction reflects a bona fide gift of the Issuer's stock to a donor-advised fund (DAF) for charitable purposes. The Reporting Person retains no beneficial ownership or control over the donated securities following the contribution.
F2 Includes 50 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan (ESPP) on December 18, 2025.